| Date | Panel | Item | Activity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Metal Metabolism Disorders v0.45 | FXYD2 |
Bryony Thompson gene: FXYD2 was added gene: FXYD2 was added to Metal Metabolism Disorders. Sources: Expert Review Amber Mode of inheritance for gene: FXYD2 was set to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted Publications for gene: FXYD2 were set to 17980699, 12763862, 18448590, 11062458, 25765846, 27014088 Phenotypes for gene: FXYD2 were set to Renal hypomagnesemia 2 MONDO:0007937, Disorders of magnesium metabolism |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||